Upsher-Smith announced the launch of dicyclomine hydrochloride tablets, USP 20 mg. This product launch is a result of Upsher-Smith's partnership with CorePharma LLC, a product developer and manufacturer.
The dicyclomine hydrochloride tablet market had U.S. sales of approximately $33 million for the 12 months ending March 2022 according to IQVIA.